138 related articles for article (PubMed ID: 7162034)
21. Role of vasopressin in the impaired water excretion of glucocorticoid deficiency.
Linas SL; Berl T; Robertson GL; Aisenbrey GA; Schrier RW; Anderson RJ
Kidney Int; 1980 Jul; 18(1):58-67. PubMed ID: 7218660
[TBL] [Abstract][Full Text] [Related]
22. Role of plasma vasopressin in impaired water excretion of glucocorticoid deficiency.
Boykin J; DeTorrenté A; Erickson A; Robertson G; Schrier RW
J Clin Invest; 1978 Oct; 62(4):738-44. PubMed ID: 701472
[TBL] [Abstract][Full Text] [Related]
23. In vivo diuretic actions of renal vasopressin V1 receptor stimulation in rats.
Ledderhos C; Mattson DL; Skelton MM; Cowley AW
Am J Physiol; 1995 Mar; 268(3 Pt 2):R796-807. PubMed ID: 7900923
[TBL] [Abstract][Full Text] [Related]
24. N-Acetyl-[2-(O-methyl)tyrosine]arginine-vasopressin, an interesting antagonist of the vasopressor response to vasopressin.
Jones DA; Sawyer WH
J Med Chem; 1980 Jun; 23(6):696-8. PubMed ID: 7392038
[TBL] [Abstract][Full Text] [Related]
25. Effective antagonists of the antidiuretic action of vasopressin in rats.
Sawyer WH; Manning M
Ann N Y Acad Sci; 1982; 394():464-72. PubMed ID: 6960778
[No Abstract] [Full Text] [Related]
26. Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors.
Butlen D; Guillon G; Rajerison RM; Jard S; Sawyer WH; Manning M
Mol Pharmacol; 1978 Nov; 14(6):1006-17. PubMed ID: 732809
[No Abstract] [Full Text] [Related]
27. Azolimine: a nonsteroidal antagonist of the effects of mineralocorticoids on renal electrolyte excretion.
Gussin RZ; Ronsberg MA; Stokey EH; Cummings JR
J Pharmacol Exp Ther; 1975 Oct; 195(1):8-15. PubMed ID: 1181406
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats.
Tsuboi Y; Ishikawa S; Fujisawa G; Okada K; Saito T
Kidney Int; 1994 Jul; 46(1):237-44. PubMed ID: 7933842
[TBL] [Abstract][Full Text] [Related]
29. Maintenance of arterial pressure by vasopressin and angiotensin II after adrenalectomy.
Elijovich F; Kirchberger M; Barry CR; Krakoff LR
Hypertension; 1983; 5(6 Pt 3):V53-6. PubMed ID: 6654464
[TBL] [Abstract][Full Text] [Related]
30. Vasopressin antagonist improves renal function in a rat model of pneumoperitoneum.
Dolgor B; Kitano S; Yoshida T; Bandoh T; Ninomiya K; Matsumoto T
J Surg Res; 1998 Oct; 79(2):109-14. PubMed ID: 9758724
[TBL] [Abstract][Full Text] [Related]
31. Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats.
Claria J; Jiménez W; Arroyo V; Guarner F; López C; La Villa G; Asbert M; Rivera F; Rodés J
Gastroenterology; 1989 Nov; 97(5):1294-9. PubMed ID: 2792662
[TBL] [Abstract][Full Text] [Related]
32. Modulation of vasopressin antidiuretic action by alpha 2-adrenoceptors is species specific.
Brooks DP; Gellai M; DePalma PD; Edwards RM
Am J Physiol; 1991 Nov; 261(5 Pt 2):R1242-6. PubMed ID: 1659234
[TBL] [Abstract][Full Text] [Related]
33. Effect of V1/V2-receptor antagonism on renal function and response to vasopressin in conscious dogs.
Rose CE; Rose KY; Kinter LB
Am J Physiol; 1991 Feb; 260(2 Pt 2):F273-82. PubMed ID: 1825453
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and renal effects of Ala-Gly-[Arg8]-vasopressin.
Chan YL; Smith CW
Biochem Biophys Res Commun; 1980 Sep; 96(2):626-31. PubMed ID: 7426004
[No Abstract] [Full Text] [Related]
35. A comparison of some activities of arginine vasopressin and lysine vasopressin on kidney function in conscious dogs.
ALI MN
Br J Pharmacol Chemother; 1958 Jun; 13(2):131-7. PubMed ID: 13536276
[TBL] [Abstract][Full Text] [Related]
36. Vasopressin-dependent upregulation of aquaporin-2 gene expression in glucocorticoid-deficient rats.
Saito T; Ishikawa SE; Ando F; Higashiyama M; Nagasaka S; Sasaki S
Am J Physiol Renal Physiol; 2000 Sep; 279(3):F502-8. PubMed ID: 10966929
[TBL] [Abstract][Full Text] [Related]
37. Effect of vasopressin antagonist d(CH2)5Tyr(Et)VAVP on plasma arginine vasopressin level after osmotic stimulus.
László FA; Laczi F; Janáky T; Baláspiri L
Endocr Regul; 1991 Sep; 25(3):181-3. PubMed ID: 1764609
[TBL] [Abstract][Full Text] [Related]
38. Role of vasopressin in cardiac, pulmonary, hepatic, and adrenal disorders.
Bichet DG; Schrier RW
Adv Nephrol Necker Hosp; 1984; 13():51-74. PubMed ID: 6433672
[No Abstract] [Full Text] [Related]
39. Drug-induced inhibition of the diuretic response to water loading in partial vasopressin responsive nephrogenic diabetes insipidus.
Radó JP; Szende L; Takó J
Int J Clin Pharmacol; 1974 Jul; 10(1):64-9. PubMed ID: 4851449
[No Abstract] [Full Text] [Related]
40. [Influence of adrenalectomy and glucocorticoid hormones on water permeability of superficial nephron segments in the rat kidney].
Stolte H; Brecht JP; Wiederholt M; Hierholzer K
Pflugers Arch Gesamte Physiol Menschen Tiere; 1968; 299(2):99-127. PubMed ID: 5247219
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
